A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder	Active, not recruiting	Phase 3	2026-09-08		NCT02834637

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institut Català d'Oncologia	14
Karolinska Institutet	493
London School of Hygiene and Tropical Medicine	58
National Cancer Institute (NCI)	3015
National Institute for Medical Research, Tanzania	8
Technische Universität Berlin	3
University of Glasgow	73
University of York	13

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mwanza Intervention Trials Unit (MITU)	Mwanza	Tanzania	1